Your browser doesn't support javascript.
loading
Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis.
Eswarakumar, V P; Ozcan, F; Lew, E D; Bae, J H; Tomé, F; Booth, C J; Adams, D J; Lax, I; Schlessinger, J.
Affiliation
  • Eswarakumar VP; Department of Pharmacology and Section of Comparative Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Proc Natl Acad Sci U S A ; 103(49): 18603-8, 2006 Dec 05.
Article in En | MEDLINE | ID: mdl-17132737
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Mutagenesis, Site-Directed / Craniosynostoses / Receptor, Fibroblast Growth Factor, Type 2 Type of study: Prognostic_studies Limits: Animals Language: En Journal: Proc Natl Acad Sci U S A Year: 2006 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Mutagenesis, Site-Directed / Craniosynostoses / Receptor, Fibroblast Growth Factor, Type 2 Type of study: Prognostic_studies Limits: Animals Language: En Journal: Proc Natl Acad Sci U S A Year: 2006 Document type: Article Affiliation country: United States Country of publication: United States